As ectopic expression of the KCC2-NTD works independently of full-length KCC2-dependent regulation of Cl− transport or structural KCC2 C-terminus-dependent regulation of synaptogenesis, our study may pave the way for a selective neuroprotective therapeutic strategy that will be applicable to a wide range of neurodegenerative diseases. This evidence concerns the gene SLC12A5 and neurodegenerative disease.